A detailed history of Raymond James & Associates transactions in Koru Medical Systems, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 77,800 shares of KRMD stock, worth $318,202. This represents 0.0% of its overall portfolio holdings.

Number of Shares
77,800
Previous 77,800 -0.0%
Holding current value
$318,202
Previous $206,000 2.91%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$2.06 - $2.99 $107,532 - $156,078
52,200 Added 203.91%
77,800 $206,000
Q1 2024

Apr 22, 2024

BUY
$2.04 - $2.38 $52,224 - $60,928
25,600 New
25,600 $60,000
Q1 2021

May 14, 2021

SELL
$3.28 - $5.82 $55,133 - $97,828
-16,809 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$3.78 - $7.36 $63,538 - $123,714
16,809 New
16,809 $101,000
Q2 2020

Jul 28, 2020

SELL
$6.84 - $12.42 $75,924 - $137,862
-11,100 Closed
0 $0
Q1 2020

Apr 21, 2020

BUY
$5.28 - $10.24 $58,608 - $113,664
11,100 New
11,100 $83,000

Others Institutions Holding KRMD

About KORU Medical Systems, Inc.


  • Ticker KRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 45,033,100
  • Market Cap $184M
  • Description
  • KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneou...
More about KRMD
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.